Sleep-EEG Research
Characterized for its association with delta-wave (slow-wave) EEG activity in animal sleep models.
Overview
DSIP (delta sleep-inducing peptide) is a nine-residue peptide, Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu. It was characterized in 1977 by Schoenenberger and Monnier as a delta-electroencephalogram (sleep)-inducing peptide in rabbit studies, which gave the peptide its name.
Published preclinical work has examined DSIP-like immunoreactivity in brain, peripheral tissues and plasma, and the peptide's effects on electrophysiological activity, neurotransmitter levels, circadian and locomotor patterns, and hormonal parameters. Its mechanism of action remains incompletely characterized and is still described in the literature as an open question.
Suria's DSIP is offered for laboratory research.
Research Use Only. Not for human or veterinary use.
Specifications
Certificate of Analysis
Certificate of Analysis
Checking certificate…
Other documentation: Batch Documentation.
Research Highlights
Characterized for its association with delta-wave (slow-wave) EEG activity in animal sleep models.
Examined in preclinical studies of hormonal levels and neurotransmitter activity.
Studied for effects on circadian and locomotor activity patterns in experimental models.
Its mechanism of action remains incompletely characterized, an open question in neuropeptide research.
Selected Literature
Literature is cited for scientific context only. Suria makes no claims regarding any use of this material outside laboratory research.
Storage
Store as specified above, protected from light and moisture, until ready for reconstitution.
Store at 2–8°C and use within the laboratory's established handling window.
Avoid repeated freeze-thaw cycles to help preserve peptide integrity across a research protocol.
Research Use Only. Not for human consumption.
Frequently Asked Questions
Batch Documentation